A Physiologic Approach to the Pharmacogenomics of Hypertension.

@article{Eadon2016APA,
  title={A Physiologic Approach to the Pharmacogenomics of Hypertension.},
  author={Michael T Eadon and Arlene B. Chapman},
  journal={Advances in chronic kidney disease},
  year={2016},
  volume={23 2},
  pages={91-105}
}
Hypertension is a multifactorial condition with diverse physiological systems contributing to its pathogenesis. Individuals exhibit significant variation in their response to antihypertensive agents. Traditional markers, such as age, gender, diet, plasma renin level, and ethnicity, aid in drug selection. However, this review explores the contribution of genetics to facilitate antihypertensive agent selection and predict treatment efficacy. The findings, reproducibility, and limitations of… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 181 references

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.Clin

  • EadonMT, Z Desta, KD Levy
  • Pharmacol Ther. 2016 Feb 6. http://dx.doi.org/10…
  • 2016
2 Excerpts

Genetic variants of C-5312T REN increased renin levels and diastolic blood pressure response to angiotensin receptor blockers

  • MS Rohman, IA Dewi Satiti, N Widodo, M Lukitasari, H. Sujuti
  • Int J Hypertens
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…